-
January 11, 2013
Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust ...
-
January 10, 2013
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced the submission of a marketing application to ...
-
January 08, 2013
Alnylam Pharmaceuticals Inc (ALNY) recently announced its goal for the next two years (2013 and 2014) regarding its ...
-
January 02, 2013
It's every investor's dream. And this one came true...
For lucky shareholders in this formerly tiny maker of ...
-
December 28, 2012
Investors got a triple-dose of bad biotech news this week.
-
December 24, 2012
GlaxoSmithKline (GSK) recently announced that it has received US Food and Drug Administration (FDA) approval for its ...
-
December 21, 2012
GlaxoSmithKline (GSK) and partner Amicus Therapeutics (FOLD) recently presented disappointing top-line six-month ...
-
December 20, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced that they have submitted a marketing ...
-
December 20, 2012
Talks between Democrats and Republicans on the Fiscal Cliff issue took a negative turn, dragging the benchmarks into ...
-
December 18, 2012
GlaxoSmithKline (GSK) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food ...
-
December 17, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
-
December 14, 2012
Isis Pharmaceuticals Inc. (ISIS) and AstraZeneca (AZN) recently announced that they have entered into an agreement ...
-
December 10, 2012
Roche Holding (RHHBY) recently announced survival data from its phase III CLEOPATRA study on Perjeta (pertuzumab). ...
-
December 07, 2012
We have reaffirmed our Neutral recommendation on Life Technologies (LIFE) with a target price of $52.00. The ...
-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
-
December 06, 2012
AstraZeneca (AZN) recently announced that it has reached an agreement with the US Food and Drug Administration (FDA) ...
-
December 05, 2012
Theravance, Inc. (THRX) recently announced the commencement of a phase II study (n~375) regarding its pipeline ...
-
December 03, 2012
Good news flowed in at Gilead Sciences Inc. (GILD) from Europe regarding its drug Viread. The European Commission ...
-
December 03, 2012
We are maintaining our Neutral recommendation on Alexion Pharmaceuticals, Inc. (ALXN) with a target price of ...
